Stocks
Veraxa Biotech AGVRXA
NASDAQHealthcareBiotechnology$1.05
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for rare genetic disorders. Its lead programs target diseases with high unmet medical need, and investors track it for its pipeline milestones and potential partnership opportunities.
52W Range: $0.99-$27.36
Congressional Interest in Veraxa Biotech AG (VRXA)
No congressional trades have been disclosed for Veraxa Biotech AG (VRXA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VRXA?
No congressional trades found for this stock.